CSRXP: NEW MOST EXPENSIVE DRUG IN THE WORLD CARRIES PRICE TAG $600,000 HIGHER THAN ESTIMATES FOR A FAIR PRICE

11-30-2022 Press Release

Hemgenix Pricing Reflects Escalating Big Pharma Trend of Setting Higher and More Out-of-Control Launch Prices on New Products For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today in response to pharmaceutical companies CSL Behring and uniQure setting a $3.5 million price tag on […]

CSRXP: OUTRAGEOUS PRICE TAG ON NEW DIABETES DRUG LATEST EXAMPLE OF BIG PHARMA’S OUT-OF-CONTROL LAUNCH PRICES

11-21-2022 Press Release

Drug Company Sets Nearly $200,000 Price on Newly Approved Treatment for Type 1 Diabetes, Blowing Past Wall Street Expectations For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today in response to Provention Bio setting a $193,900 price tag for a course of treatment […]

CSRXP APPLAUDS FDA APPROVAL OF SECOND INTERCHANGEABLE BIOSIMILAR FOR INSULIN

11-18-2022 Press Release

Interchangeable Biosimilars Help Provide Patients with Greater Choice and More Affordable Alternatives to High-Priced Brand Name Drugs For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today in response to the Food and Drug Administration’s (FDA) decision to approve interchangeable biologic drug Rezvoglar, as […]

CSRXP: PFIZER’S EGREGIOUS VACCINE PRICE HIKE DEMONSTRATES URGENCY TO BUILD ON POSITIVE PROGRESS TO HOLD BIG PHARMA ACCOUNTABLE

10-21-2022 Press Release

Big Pharma Companies Want to Price-Gouge the American People and Health Care System as COVID-19 Vaccine and Therapeutic Coverage Shifts to Commercial Market For Immediate ReleaseContact: Jon [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday in response to reports that brand name pharmaceutical giant Pfizer is planning to hike the price of the […]

CSRXP: BIG PHARMA’S EGREGIOUS $158,000 PRICE TAG ON UNPROVEN ALS TREATMENT MIRRORS PRICE-GOUGING OF ADUHELM

10-6-2022 Press Release

Brand Name Drug Maker Amylyx Sets Price Tag For Relyvrio Between Five And 17 Times Estimates For A Fair Price Despite Lack Of Data on Efficacy For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday reacting to brand name drug maker Amylyx setting a list […]

CSRXP: AMERICAN PATIENTS COUNTING ON CONGRESS TO BUILD ON POSITIVE PROGRESS TOWARD LOWERING DRUG PRICES, NOT GO BACKWARDS

09-26-2022 Press Release

Lawmakers Must Put Patients First And Reject Bogus Big Pharma Rhetoric For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday in response to comments from some lawmakers suggesting a repeal of drug pricing solutions passed as part of the Inflation Reduction Act of 2022. “Washington finally […]

CSRXP: MODERNA MUST BE PUT ON NOTICE THAT PATIENTS, POLICYMAKERS WOULD FIND SIX-FOLD VACCINE PRICE HIKE UNCONSCIONABLE

09-12-2022 Press Release

Big Pharma Giant Eyes Massive Price Hike on COVID-19 Vaccine Developed with $1.3 Billion Investment from American Taxpayers For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Monday reacting to reports that brand name drug company Moderna is considering hiking the price of the company’s COVID-19 vaccine as […]

CSRXP APPLAUDS PRESIDENT BIDEN FOR TAKING MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE

08-16-2022 Press Release

Biden Administration and Congress Deliver Positive Progress on Longstanding Commitments to Lower Prescription Drug Prices For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday in response to President Biden signing H.R. 5376, the Inflation Reduction Act of 2022, into law. “CSRxP applauds President Biden […]

CSRXP: CONGRESS TAKES MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE, LOWERING DRUG PRICES FOR THE AMERICAN PEOPLE

08-12-2022 Press Release

Big Pharma Can No Longer Evade Accountability and Keep Prices High by Spending Hundreds of Millions of Dollars on False and Hyperbolic Claims For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday on the U.S. House of Representatives’ passage of the Inflation Reduction Act […]

CSRXP APPLAUDS SENATE FOR MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE AND LOWERING PRESCRIPTION DRUG PRICES

08-7-2022 Press Release

Drug Pricing Solutions in Inflation Reduction Act of 2022 Will Help Crack Down on the Pharmaceutical Industry’s Egregious Practices, Deliver Relief for American Patients For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Sunday on the U.S. Senate passage of the Inflation Reduction Act […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.